Anther Keung
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 8
- Virology top 10%
- HIV Research and Treatment 5
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 3
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 5
-
- Pharmacological Effects and Toxicity Studies 6
-
- Epilepsy research and treatment 4
-
- Hepatitis C virus research 3
- Co-authors
- Hilde RosingHerbert M. PinedoJos H. BeijnenManon HuizingScott J. WeirMark G. EllerI. MandjesAnne-Charlotte Dubbelman
- Journals
- Journal of Clinical Oncology (1 paper)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Hepatology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Anther Keung
24 papers receiving 879 citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 310
- Virology 76
- Pharmacology 130
- Oncology 384
- Pharmacology 144
Countries citing papers authored by Anther Keung
This map shows the geographic impact of Anther Keung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anther Keung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anther Keung more than expected).
Fields of papers citing papers by Anther Keung
This network shows the impact of papers produced by Anther Keung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anther Keung. The network helps show where Anther Keung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anther Keung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 35 | |
| 2 | 2010 | 5 | |
| 3 | 2010 | 9 | |
| 4 | 2009 | 5 | |
| 5 | 2007 | 66 | |
| 6 | 2005 | 3 | |
| 7 | 2002 | 42 | |
| 8 | Ezetimibe does not affect the pharmacokinetics of oral contraceptives | 2001 | 27 |
| 9 | 1999 | 12 | |
| 10 | Single and multiple dose pharmacokinetics of rifapentine in man: part II. | 1999 | 41 |
| 11 | 1999 | 25 | |
| 12 | Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I. | 1999 | 29 |
| 13 | 1998 | 14 | |
| 14 | 1998 | 18 | |
| 15 | 1998 | 11 | |
| 16 | 1998 | 5 | |
| 17 | 1996 | 10 | |
| 18 | 1995 | 102 | |
| 19 | 1993 | 263 | |
| 20 | 1987 | 7 |
About Anther Keung
Anther Keung is a scholar working on Virology, Pharmacology and Infectious Diseases, having authored 24 papers that have together received 948 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers), HIV Research and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer Treatment and Pharmacology (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Infectious Diseases (310 citations), Virology (76 citations) and Pharmacology (130 citations). Anther Keung has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Hilde Rosing, Herbert M. Pinedo, Jos H. Beijnen, Manon Huizing, Scott J. Weir, Mark G. Eller, I. Mandjes, Anne-Charlotte Dubbelman, W.W. ten Bokkel Huinink and Lip Yong Chung. Their work appears in journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.